Search for: "Bristol Myers Squibb Manufacturing Company" Results 21 - 40 of 162
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
22 Jun 2017, 11:23 am by Michael J. Mueller
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
3 Sep 2015, 7:34 am by Law Offices of Jeffrey S. Glassman
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. [read post]
20 Jul 2007, 7:39 pm
This week, shortly before trial, pharmaceutical manufacturer Bristol-Myers Squibb Co. reportedly agreed to pay $13 million to resolve allegations that it overcharged for its Taxol cancer medicine and other drugs. [read post]
16 Apr 2021, 5:00 am by Daniel E. Cummins, Esq.
Supreme Court’s previous rejection in Bristol-Myers of specific jurisdiction over claims by non-resident plaintiffs against a non-resident company whose product allegedly injured the plaintiffs. [read post]
23 Feb 2017, 7:21 am by Altman & Altman
As of December 2016, approximately 34 Eliquis lawsuits were pending against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, Inc. [read post]
3 Apr 2009, 8:31 am by VC
Case Study – 01 Let us take example of Bristol-Myer Squibb (BMS) patented drug Dasatinib for which Hetero Drugs filed an application with the DCGI for marketing approval of generic dossier of Dasatinib. [read post]
27 Apr 2008, 9:57 pm
  In March 2002, Sanofi-Synthelabo and Bristol-Myers Squibb sued Apotex for infringing the Orange Book-listed patent, U.S. [read post]
10 Aug 2016, 2:40 pm by Michael Grossman
Created by the Japanese company Otsuka Pharmaceutical, it is marketed in North America by Otsuka America and their partner company Bristol Myers-Squibb, an enormous biopharmaceutical manufacturer/marketer. [read post]
5 May 2009, 5:57 am
Supreme Court decided patients can sue drugmakers over injuries from medicines approved by the government, long-stalled lawsuits against GlaxoSmithKline Plc and Bristol-Myers Squibb Co. are again moving toward trials. [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
2 Apr 2009, 1:01 pm
In our first post we particularly analyzed that both Bristol-Myer Squibb (BMS) and the Delhi High Court acted within the periphery of the law and the Delhi HC order nowhere created any sort of "patent-drug regulatory" linkage, an argument unnecessarily sensationalized and propagandized by newspaper media. [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
30 Sep 2010, 2:16 pm by Mark Zamora
Image via WikipediaBristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.The company said it took the action on behalf of the Bristol-Myers Squibb/Sanofi-Synthelabo partnership because of a potential variability in levels of the less-soluble form of the active ingredient in Avalide, irbesartan, which could result in slower dissolution.Bristol-Myers … [read post]
22 Oct 2020, 5:39 am by Daniel E. Cummins, Esq.
  The Court reviewed several notable United States Supreme Court Opinions, the most recent of which was in the case of Bristol-Myers Squibb Co. v. [read post]